HomeInsightsMarket Capitalization

Market Capitalization of Lupin Ltd

Market Capitalization of Lupin Ltd

stocks purchased

₹ 7.5 Cr

Volume transacted

stocks purchased

33.9 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Lupin Ltd

NSE: LUPIN

MARKETCAP

101460.93 crore

Last updated: 18 Sep 24

Key Highlights

  • The Market Cap of Lupin Ltd is ₹ 101460 crore as of 18 Sep 24.
  • The Market Cap of Lupin Ltd changed from ₹ 33443 crore on March 2019 to ₹ 73722 crore on March 2024 . This represents a CAGR of 14.08% over 6 years. .
  • The Latest Trading Price of Lupin Ltd is ₹ 2224 as of 18 Sep 15:30.

Historical Market Cap of Lupin Ltd

No data available

* All values are in crore

Company Fundamentals for Lupin Ltd

No data available

Image

Lupin Ltd

NSE: LUPIN

PRICE

2224.35

-46.25 (-2.04%)

stock direction

Last updated: 18 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Lupin Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 20242224.35
17 Sep 20242270.6
16 Sep 20242252.25
13 Sep 20242253.55
12 Sep 20242246.85
11 Sep 20242208.95
10 Sep 20242222.4
09 Sep 20242216.95
06 Sep 20242257.25
05 Sep 20242288.35

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lupin Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Lupin Ltd441,01,460
Sun Pharmaceuticals Industries Ltd414,39,714
Divis Laboratories Ltd861,45,166
Cipla Ltd301,33,402
Torrent Pharmaceuticals Ltd681,13,724
Dr Reddys Laboratories Ltd191,09,604

Key Valuation Metric of Lupin Ltd

No data available

Historical P/E Ratio of Lupin Ltd

No data available

* All values are in %

Historical Revenue of Lupin Ltd

No data available

* All values are in crore

Historical EBITDA of Lupin Ltd

No data available

* All values are in crore

Historical Net Profit of Lupin Ltd

No data available

* All values are in crore

Historical Dividend Payout of Lupin Ltd

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.
  • Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.
  • In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd.

Lupin Ltd News Hub

News

Lupin enters into patent license agreement with Takeda

Lupin announced that it has entered into a non-exclusive patent license agreement with Tak...

Read more

18 Sep 202413:43

News

Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India

Vonoprazan is a novel potassium-competitive acid blocker (P-CAB). Unlike traditional acid ...

Read more

18 Sep 202414:50

News

Lupin gains on inking pact to acquire 43% stake in Sunsure Solarpark

Sunsure Solarpark, a subsidiary of Sunsure Energy, is a renewable energy company focused o...

Read more

12 Sep 202412:26

News

Lupin Ltd soars 1.38%, up for third straight session

Lupin Ltd rose for a third straight session today. The stock is quoting at Rs 2308.6, up 1...

Read more

05 Sep 202413:05

News

Lupin launches Mirabegron Extended-Release Tablets in US

 Lupin announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United S...

Read more

04 Sep 202415:07

News

Lupin hits life high on launching overactive bladder drug in US

Mirabegron extended-release tablets are used to treat the symptoms of an overactive bladde...

Read more

04 Sep 202415:15

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Lupin Ltd

What is the market cap of Lupin Ltd?

As of September 18, 2024, Lupin Ltd has a market capitalization of ₹101460.93, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Lupin Ltd's market capitalization?

Lupin Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Lupin Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Lupin Ltd's market capitalization change?

Lupin Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*